Singing Program Feasible After Pulmonary Rehabilitation

Study finds 12-week singing intervention feasible following pulmonary rehabilitation, supporting larger trial.

By
Olivia Anderson
March 10, 2026
3 min

Conexiant

Overview

A structured singing program following pulmonary rehabilitation is feasible and acceptable for patients with chronic respiratory disease. The study indicates potential benefits and supports the need for a larger randomized controlled trial.

Background

Pulmonary rehabilitation (PR) is a gold standard treatment for chronic respiratory diseases, improving symptoms and quality of life. However, benefits often diminish after program completion, highlighting the need for effective maintenance strategies. This study explores the feasibility of a singing program as a potential adjunct to sustain the benefits of PR.

Data Highlights

Measure	SLH Group	Control Group
Participants Attending ≥8 Sessions	20 (63%)	N/A
12-Week Follow-Up Completion	59 (92%)	N/A
Adverse Events	50	53
Serious Adverse Events	8	18

Key Findings

A total of 64 participants were randomized to either usual care or a 12-week singing program.
63% of participants in the singing group attended at least 8 out of 12 sessions.
92% of participants completed the 12-week follow-up assessment.
Exploratory analyses indicated effect sizes greater than 0.4 for physical performance and lung function measures.
No safety concerns were identified related to the singing intervention.

Clinical Implications

The findings suggest that a singing program could be a viable maintenance strategy for patients post-pulmonary rehabilitation. Healthcare providers may consider incorporating such programs to enhance patient engagement and support ongoing respiratory health.

Conclusion

The study demonstrates that a singing program is feasible and may provide additional benefits for patients after pulmonary rehabilitation, warranting further investigation through a larger trial.